Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 37,000 NKTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Nkarta, Inc. (NKTX) | Grant/Award | 37,000 | n/a |
| Jun 9, 2026 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 10,000 | n/a |
| Jun 4, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 9,000 | n/a |
| Feb 9, 2026 | SpyGlass Pharma, Inc. (SGP) | Grant/Award | 27,400 | n/a |
| Dec 29, 2025 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 1,500 | n/a |
| Jun 10, 2025 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 50,000 | n/a |
| Jun 9, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 46,000 | n/a |
| Apr 11, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 18,000 | n/a |
| Jun 14, 2024 | Nkarta, Inc. (NKTX) | Grant/Award | 22,500 | n/a |
| Jun 10, 2024 | SUTRO BIOPHARMA, INC. (STRO) | Grant/Award | 35,000 | n/a |